Figure 4 illustrates the effects of IL-33/ST2 signaling in tumor development. In Table 1, we summarize the pro- and/or anti-tumorigenic effects of IL-33/ST2 in various cancers and indicate the experimental models used to support the observed function as well as the references. The gene discussed is IL33; the disease is cancer.